Published in Cytokine Growth Factor Rev on October 16, 2010
Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One (2012) 1.04
IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J Clin Immunol (2012) 0.84
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells. Oncotarget (2015) 0.82
A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy. J Interferon Cytokine Res (2013) 0.80
The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin. Mol Oncol (2014) 0.79
Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment. Arthritis Res Ther (2012) 0.79
Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A. PLoS One (2012) 0.79
Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms. Am J Physiol Cell Physiol (2016) 0.77
Purification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis. Arthritis Rheumatol (2014) 0.75
The Role of the IL-20 Subfamily in Glaucoma. Mediators Inflamm (2016) 0.75
Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis. Sci Rep (2016) 0.75
IL-20 Signaling in Activated Human Neutrophils Inhibits Neutrophil Migration and Function. J Immunol (2017) 0.75
A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells. Oncotarget (2017) 0.75